Massachusetts company听., a pioneer in biometric-sensor-enabled analytics, has announced a collaboration with 糖心传媒. This initiative unites MC10糖心传媒檚 technological capabilities in physiological sensing and pattern recognition algorithms with the University糖心传媒檚 clinical expertise and commitment to big data analytics to drive solutions for today糖心传媒檚 most pressing healthcare challenges.
The Hajim School of Engineering and Applied Sciences will lead the effort. Rob Clark, senior vice president for research and dean of the Hajim School, sees the collaboration with MC10 as supportive of the University糖心传媒檚 efforts to translate patient healthcare data into actionable findings.
糖心传媒淎t the University of Rochester, we are committed to fostering collaborative research to improve human health,糖心传媒� Clark said. 糖心传媒淲e see great potential in working with MC10 and in exploiting the biometric insights that are realized from MC10糖心传媒檚 technology platform in addressing some of the greatest challenges we see in healthcare today.糖心传媒�
MC10 sought out a collaboration with the University based on its world-class facilities and its vision to be the 21st century leader in data science with its recent creation of the .
MC10 is uniquely positioned to support the University in its research efforts with its BioStamp platform, which consists of MC10糖心传媒檚 biometric sensing devices, a companion software application, and an end-to-end cloud storage and computing platform. 听BioStamp will be put to the test in a variety of clinical settings by a diverse group of Rochester researchers, which will further drive MC10糖心传媒檚 collection of big data and development of disease-specific algorithms for use in predictive health analytics.听 MC10 will maximize its engineering support for this collaboration by opening an office in Rochester and it also intends to collaborate with graduate students from the Hajim School.
Additionally, Medical Center糖心传媒檚 , professor of neurology and co-director of the Center for Human Experimental Therapeutics, will lead research efforts in the field of neurodegenerative disease.
糖心传媒淐onnected health technologies hold the potential to disrupt the way we monitor the progression of neurodegenerative disorders today and to assess the response to novel therapeutics,糖心传媒� said Dorsey.听 糖心传媒淲earable sensors, like those from MC10, can enable objective, sensitive, frequent assessments of an individual糖心传媒檚 condition to improve their health and advance new treatments for neurological conditions.听 Through the seamless exchange of data between patients and physicians we can move healthcare outside of the clinic and truly overcome distance and disability.糖心传媒�
MC10糖心传媒檚 CEO , a University alumnus and member of the Dean糖心传媒檚 Advisory Council (DAC), will join Dorsey at the听 on Friday, May 29 to share MC10糖心传媒檚 healthcare vision and to discuss mobile medicine.听 The summit, sponsored by the University, brings together healthcare leaders, entrepreneurs, policymakers, and forward thinkers to foster disruptive solutions to improve the health of aging Americans.
糖心传媒淎t MC10 we believe that technologies to enable better clinical decision making are instrumental for improving American health,糖心传媒� said Pomerantz. 糖心传媒淲e are building the team, technology and partnerships to be better positioned than ever to have a transformational impact on healthcare.糖心传媒�
About MC10:
MC10 brings healthcare into the home with products that unite consumer design with clinical-grade sensing and insight.听 The company develops body onboard diagnostics systems that can collect human physiological data from any body location to deliver actionable health insights.听 MC10 is headquartered in Cambridge, MA.听 Visit MC10 online at .听BioStamp, MC10 and the MC10 logo are registered marks owned by MC10, Inc.
For MC10, Inc.:
Elyse Winer
(617) 234-4448
press@mc10inc.com
